{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"columns":[{"gene":"","key":"MONDO:0030935/OMIM:619166","label":"Mitochondrial complex II deficiency, nuclear type 2","mondoId":"MONDO:0030935","onsetQualifier":null,"recordKeys":["25620f0c336ef5e3b5fdff9825975c106501d584a310745deb4269efa1db8ecd","432286eeebd75226c82871a8e60d8d9b6fb78be24eb43f14a795388bc47a1255","bb9af50d38a292a24b3fdf3785079e188fa5ecbf7f925193fbc0c8dfd894e954","bf7d7db63e620048c602f77c35df73b794b1f76d9e088c509d88a0f07c684be4","cb7adf9b3f478e0be64a8df9290e40641148fdaef0bcbba955e06b58729dea45","d2850ac0d0757b6a729af9a880191c36a0ba6997693faf66e07d886982341306"],"recordQualifiers":{},"scopeLabel":"OMIM:619166","sourceIds":["OMIM:619166"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0030935/OMIM:619166"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.</p>"},"coverage":{"countRecords":5,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":6,"sourceGroups":{"omim":0,"orphanet":0,"published":6}},"features":[{"hpoId":"HP:0002376","label":"Developmental regression","primary":false},{"hpoId":"HP:0001510","label":"Growth delay","primary":false},{"hpoId":"HP:0000737","label":"Irritability","primary":false},{"hpoId":"HP:0002352","label":"Leukoencephalopathy","primary":false},{"hpoId":"HP:0012708","label":"Reduced brain N-acetyl aspartate level by MRS","primary":false},{"hpoId":"HP:0002510","label":"Spastic tetraplegia","primary":false}],"ledeHtml":"A patient-friendly description is not yet available in the ingested narrative sources for this condition.","mondoId":"MONDO:0030935","records":[{"frequencyKind":"count","key":"25620f0c336ef5e3b5fdff9825975c106501d584a310745deb4269efa1db8ecd","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:619166","disease_name":"Mitochondrial complex II deficiency, nuclear type 2","evidence":"PCS","frequency_raw":"6/7","hpo_id":"HP:0001510","is_excluded":false,"label":"Growth delay","onset_id":null,"reference":"PMID:19465911","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"432286eeebd75226c82871a8e60d8d9b6fb78be24eb43f14a795388bc47a1255","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:619166","disease_name":"Mitochondrial complex II deficiency, nuclear type 2","evidence":"PCS","frequency_raw":"7/7","hpo_id":"HP:0002510","is_excluded":false,"label":"Spastic tetraplegia","onset_id":null,"reference":"PMID:19465911","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"bb9af50d38a292a24b3fdf3785079e188fa5ecbf7f925193fbc0c8dfd894e954","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:619166","disease_name":"Mitochondrial complex II deficiency, nuclear type 2","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0012708","is_excluded":false,"label":"Reduced brain N-acetyl aspartate level by MRS","onset_id":null,"reference":"PMID:19465911","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"bf7d7db63e620048c602f77c35df73b794b1f76d9e088c509d88a0f07c684be4","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:619166","disease_name":"Mitochondrial complex II deficiency, nuclear type 2","evidence":"PCS","frequency_raw":"3/7","hpo_id":"HP:0000737","is_excluded":false,"label":"Irritability","onset_id":null,"reference":"PMID:19465911","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"cb7adf9b3f478e0be64a8df9290e40641148fdaef0bcbba955e06b58729dea45","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:619166","disease_name":"Mitochondrial complex II deficiency, nuclear type 2","evidence":"PCS","frequency_raw":"6/6","hpo_id":"HP:0002352","is_excluded":false,"label":"Leukoencephalopathy","onset_id":null,"reference":"PMID:19465911","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"d2850ac0d0757b6a729af9a880191c36a0ba6997693faf66e07d886982341306","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:619166","disease_name":"Mitochondrial complex II deficiency, nuclear type 2","evidence":"PCS","frequency_raw":"7/7","hpo_id":"HP:0002376","is_excluded":false,"label":"Developmental regression","onset_id":null,"reference":"PMID:19465911","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p>No mapped MedlinePlus condition document in this snapshot.</p>","identityNote":"MONDO defines condition identity and route membership. Native evidence populations and narrative coverage retain their separate scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>No MedlinePlus narrative has been mapped to this MONDO condition. Feature annotations, when available, are retained below.</p>","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"mitochondrial-complex-2-deficiency-nuclear-type-2","sourceDocuments":[],"sourceNote":"MONDO condition identity; scoped MedlinePlus enrichment where available; original HPO annotations.","takeawayHtml":"Cause information is not available in the mapped narrative sources for this condition.","title":"mitochondrial complex 2 deficiency, nuclear type 2"},"schemaVersion":1}